// App-Quantinova.ai

: Culturally appropriate advisory and governance oversight for the study of rheumatic fever and rheumatic heart disease in New Zealand

Researchers

Presenter

  • Dianne Sika-Paotonu

Principal Investigators

  • Pedro Azevedo

  • Allamanda Faatoese

  • Helen Wihongi

  • Hiueni Nuku

  • Maui Hudson

  • Palatasa Havea

  • Tom Parks

  • Tony Merriman

  • Diana Lennon

Medical Centers

  • Victoria University, Wellington, New Zealand

  • Telethon Kids Institute, Perth, Australia

  • Hospital Israelita Albert Einstein,

  • University of Otago, Dunedin, New Zealand

  • Auckland, Waitemata DHB, New Zealand

  • Porirua Union and Community Health Services, New Zealand

  • University of Waikato, New Zealand

  • Fonterra, New Zealand

  • University of Oxford, Oxford, United Kingdom

  • University of Auckland, Auckland, New Zealand

Locations

  • Australia

  • Brazil

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Rheumatic heart disease

Biomarkers

  • Cyclin Dependent Kinase Inhibitor 2A

  • Gastrin

  • Interleukin 6

Drug/Treatment

  • Interleukin

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved